1 Market Overview
1.1 Product Overview and Scope of Diabetes Therapy and Drug Delivery
1.2 Classification of Diabetes Therapy and Drug Delivery by Type
1.2.1 Overview: Global Diabetes Therapy and Drug Delivery Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type in 2020
1.2.3 Inhalable Insulin
1.2.4 Oral Insulin
1.2.5 Insulin Patches
1.2.6 CGM Systems
1.2.7 Artificial Pancreas
1.3 Global Diabetes Therapy and Drug Delivery Market by Application
1.3.1 Overview: Global Diabetes Therapy and Drug Delivery Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Global Diabetes Therapy and Drug Delivery Market Size & Forecast
1.5 Global Diabetes Therapy and Drug Delivery Market Size and Forecast by Region
1.5.1 Global Diabetes Therapy and Drug Delivery Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Diabetes Therapy and Drug Delivery Market Size by Region, (2016-2021)
1.5.3 North America Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.4 Europe Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.6 South America Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Diabetes Therapy and Drug Delivery Market Drivers
1.6.2 Diabetes Therapy and Drug Delivery Market Restraints
1.6.3 Diabetes Therapy and Drug Delivery Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Diabetes Therapy and Drug Delivery Product and Solutions
2.1.4 Abbott Laboratories Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Diabetes Therapy and Drug Delivery Product and Solutions
2.2.4 Medtronic Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Medtronic Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Diabetes Therapy and Drug Delivery Product and Solutions
2.3.4 Sanofi Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business
2.4.3 Novo Nordisk Diabetes Therapy and Drug Delivery Product and Solutions
2.4.4 Novo Nordisk Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novo Nordisk Recent Developments and Future Plans
2.5 MannKind
2.5.1 MannKind Details
2.5.2 MannKind Major Business
2.5.3 MannKind Diabetes Therapy and Drug Delivery Product and Solutions
2.5.4 MannKind Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 MannKind Recent Developments and Future Plans
2.6 Enteris BioPharma
2.6.1 Enteris BioPharma Details
2.6.2 Enteris BioPharma Major Business
2.6.3 Enteris BioPharma Diabetes Therapy and Drug Delivery Product and Solutions
2.6.4 Enteris BioPharma Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Enteris BioPharma Recent Developments and Future Plans
2.7 Dexcom
2.7.1 Dexcom Details
2.7.2 Dexcom Major Business
2.7.3 Dexcom Diabetes Therapy and Drug Delivery Product and Solutions
2.7.4 Dexcom Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Dexcom Recent Developments and Future Plans
2.8 Senseonics Holding
2.8.1 Senseonics Holding Details
2.8.2 Senseonics Holding Major Business
2.8.3 Senseonics Holding Diabetes Therapy and Drug Delivery Product and Solutions
2.8.4 Senseonics Holding Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Senseonics Holding Recent Developments and Future Plans
2.9 Medtech
2.9.1 Medtech Details
2.9.2 Medtech Major Business
2.9.3 Medtech Diabetes Therapy and Drug Delivery Product and Solutions
2.9.4 Medtech Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Medtech Recent Developments and Future Plans
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Diabetes Therapy and Drug Delivery Product and Solutions
2.10.4 Johnson & Johnson Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Johnson & Johnson Recent Developments and Future Plans
2.11 Synertech
2.11.1 Synertech Details
2.11.2 Synertech Major Business
2.11.3 Synertech Diabetes Therapy and Drug Delivery Product and Solutions
2.11.4 Synertech Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Synertech Recent Developments and Future Plans
2.12 Zosano Pharma
2.12.1 Zosano Pharma Details
2.12.2 Zosano Pharma Major Business
2.12.3 Zosano Pharma Diabetes Therapy and Drug Delivery Product and Solutions
2.12.4 Zosano Pharma Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Zosano Pharma Recent Developments and Future Plans
2.13 Relmada Therapeutics
2.13.1 Relmada Therapeutics Details
2.13.2 Relmada Therapeutics Major Business
2.13.3 Relmada Therapeutics Diabetes Therapy and Drug Delivery Product and Solutions
2.13.4 Relmada Therapeutics Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Relmada Therapeutics Recent Developments and Future Plans
2.14 Eli Lilly
2.14.1 Eli Lilly Details
2.14.2 Eli Lilly Major Business
2.14.3 Eli Lilly Diabetes Therapy and Drug Delivery Product and Solutions
2.14.4 Eli Lilly Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Eli Lilly Recent Developments and Future Plans
2.15 Transdermal Specialties
2.15.1 Transdermal Specialties Details
2.15.2 Transdermal Specialties Major Business
2.15.3 Transdermal Specialties Diabetes Therapy and Drug Delivery Product and Solutions
2.15.4 Transdermal Specialties Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Transdermal Specialties Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Diabetes Therapy and Drug Delivery Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Diabetes Therapy and Drug Delivery Players Market Share
3.2.2 Top 10 Diabetes Therapy and Drug Delivery Players Market Share
3.2.3 Market Competition Trend
3.3 Diabetes Therapy and Drug Delivery Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Diabetes Therapy and Drug Delivery Revenue and Market Share by Type (2016-2021)
4.2 Global Diabetes Therapy and Drug Delivery Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2016-2021)
5.2 Diabetes Therapy and Drug Delivery Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
6.2 North America Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
6.3 North America Diabetes Therapy and Drug Delivery Market Size by Country
6.3.1 North America Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
6.3.2 United States Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
6.3.3 Canada Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
6.3.4 Mexico Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
7.2 Europe Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
7.3 Europe Diabetes Therapy and Drug Delivery Market Size by Country
7.3.1 Europe Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
7.3.2 Germany Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.3 France Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.5 Russia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.6 Italy Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
8.2 Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
8.3 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Region (2016-2026)
8.3.2 China Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.3 Japan Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.4 South Korea Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.5 India Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.7 Australia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
9.2 South America Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
9.3 South America Diabetes Therapy and Drug Delivery Market Size by Country
9.3.1 South America Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
9.3.2 Brazil Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
9.3.3 Argentina Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
10.2 Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
10.3 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
10.3.2 Turkey Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
10.3.4 UAE Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
【掲載企業】
Abbott Laboratories、Medtronic、Sanofi、Novo Nordisk、MannKind、Enteris BioPharma、Dexcom、Senseonics Holding、Medtech、Johnson & Johnson、Synertech、Zosano Pharma、Relmada Therapeutics、Eli Lilly、Transdermal Specialties
【免責事項】
https://www.globalresearch.jp/disclaimer